NEFM and Lewy body dementia: To investigate whether the increase in p-NfM/H immunoreactivity in the PDD/DLB group was driven by a specific clinical phenotype (PDD or DLB), we explored the difference in p-NfM/H immunoreactivity between these groups, but observed no differences.